Change the cancer therapy landscape
NeoGenomics plays an essential role in helping our biopharma partners accelerate drug development and clinical trials, supporting your mission to save lives through innovation.
CTA style
Default
The difference is in our data
With just over 2 million patient profiles from over 40,000 unique providers across 4,000 healthcare organizations, we have access to a broad data set that encompasses the diversity of the entire US population. Our multi-modal test menu captures a wide variety of cancer diagnoses and offers supportive insights throughout the patient treatment journey.
Our oncology data solutions can deliver unparalleled insights in precision oncology.
CTA style
Default